National Guideline Clearinghouse | Aflibercept in combination with irinotecan and fluorouracil-based therapy for treating metastatic colorectal cancer that has progressed following prior oxaliplatin-based chemotherapy.

full-text ►

National Guideline Clearinghouse | Aflibercept in combination with irinotecan and fluorouracil-based therapy for treating metastatic colorectal cancer that has progressed following prior oxaliplatin-based chemotherapy.



National Institute for Health and Care Excellence (NICE)

Guideline Title

Aflibercept in combination with irinotecan and fluorouracil-based therapy for treating metastatic colorectal cancer that has progressed following prior oxaliplatin-based chemotherapy.

Bibliographic Source(s)

National Institute for Health and Care Excellence (NICE). Aflibercept in combination with irinotecan and fluorouracil-based therapy for treating metastatic colorectal cancer that has progressed following prior oxaliplatin-based chemotherapy. London (UK): National Institute for Health and Care Excellence (NICE); 2014 Mar. 65 p. (Technology appraisal guidance; no. 307).

Guideline Status

This is the current release of the guideline.